Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...
The FDA assigned INO-3107 a Prescription Drug User Fee Act (PDUFA) review goal date of October 30, 2026, which is the date by which it intends to take action on the application. The FDA has indicated ...
Engineers at the Massachusetts Institute of Technology have developed an AI-driven robotic assembly system lets users build ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback